International Biotechnology Trust PLC - investment trust - Says it plans to invest in SV Health Investors LLP's future biotechnology focussed private fund, SV Biotech Crossover Opportunities Fund LP. Explains this is in line with its strategy to maintain its exposure to unquoted companies within a 5% to 15% of net asset value range.
Current stock price: 739.00 pence
Year-to-date change: down 9.6%
By Abby Amoakuh; abbyamoakuh@alliancenews.com
Copyright 2021 Alliance News Limited. All Rights Reserved.
Int.biotech. (IBT)